drugset / Trial / NCT04752631
MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNK
RandomizedParallel-groupSingle-blindTreatment
Summary
This is an open label multicentre trial, evaluating the utility of MRI-guided thrombolysis for stroke beyond time window by Tenecteplase (TNK-tPA). This exploratory study was to describe the feasibility and outcome of thrombolytic therapy with TNK-tPA in 4.5-24 hours after stroke guided by a mismatch between diffusion-weighted imaging and FLAIR in the region of ischemia.
Timeline
- Start
- 2021-03-09
- Primary completion
- 2022-07-24
- Completion
- 2022-07-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenecteplase | Protein / enzyme biologic | 0.25 mg/kg | — |